Pediatric anesthesia & critical care

Effect of Dexmedetomidine on Cerebrovascular Carbon Dioxide Reactivity During Pediatric Cardiac Surgery With Cardiopulmonary Bypass

J Cardiothorac Vasc AnesthPublished Randomised controlled trial

Authors' conclusion

A low loading dose of DEX did not compromise CVR-CO2 in children with CHD undergoing cardiac surgery with cardiopulmonary bypass.

Study context

Population
Children aged 0 to 6 years with congenital heart disease undergoing cardiac surgery with CPB, tertiary care center in Shanghai, China
Participants
59 children
Comparison
Dexmedetomidine (DEX) vs normal saline for 10 minutes after anesthetic induction
Methodological detailssingle-centre
  • Single-centre

Primary result

As reported in the abstract

CVR-CO2
  • CVR-CO2 comparable between the two groups
  • DEX vs Control: P = 0.402

Further findings

OutcomeP value
PI, RI, Vmean, ScrO2DEX vs Control · PIP = 0.203
PI, RI, Vmean, ScrO2DEX vs Control · RIP = 0.290
PI, RI, Vmean, ScrO2DEX vs Control · VmeanP = 0.290
PI, RI, Vmean, ScrO2DEX vs Control · ScrO2P = 0.426
Hemodynamics (HR, MAP)DEX vs Control · HRP = 0.522
Hemodynamics (HR, MAP)DEX vs Control · MAPP = 0.236

Pulsatility index (PI), resistance index (RI), Vmean, ScrO2

Comparable between the two groups

Hemodynamics (HR, mean arterial pressure (MAP))

Comparable between the two groups

Change before vs after surgery (within group)

Control: PI, RI and HR significantly differed before and after surgery
DEX: RI, Vmean, ScrO2 and HR significantly differed before and after surgery

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Effect of Dexmedetomidine on Cerebrovascular Carbon Dioxide Reactivity During Pediatric Cardiac Surgery With Cardiopulmonary Bypass. J Cardiothorac Vasc Anesth. Published 3 March 2025. doi:10.1053/j.jvca.2025.03.002

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.